General Information of the Compound
Compound ID
CP0037780
Compound Name
(2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid
    Show/Hide
Synonyms
((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine
(2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
(2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid
AC1L972Z
AKOS026750073
BDBM50010142
Bestatin
Bestatin (TN)
C00732
CHEBI:140702
CHEBI:3070
CHEMBL476869
D00087
DTXSID4048430
GTPL5151
NCGC00161660-01
SCHEMBL25971
SureCN25971
UPCMLD-DP116
UPCMLD-DP116:001
Ubenimex (JP16/INN)
Ubenimex (JP17/INN)
ZINC01532730
ZINC1532730
    Show/Hide
Structure
Formula
C16H24N2O4
Molecular Weight
308.378
Canonical SMILES
CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1
    Show/Hide
InChIKey
VGGGPCQERPFHOB-RDBSUJKOSA-N
CAS
58970-76-6
Physicochemical Property
logP
0.5328
Rotatable Bonds
8
Heavy Atom Count
22
Polar Areas
112.65
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6992132
SID: 12013068
ChEMBL ID
CHEMBL29292
DrugBank ID
DB03424
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01820, Aminopeptidase N
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000377 ES-2 Homo sapiens (Human)  3
1
IC50 = 20120 nM
   TI
   LI
   LO
   TS
2
IC50 = 29670 nM
   TI
   LI
   LO
   TS
3
IC50 = 35500 nM
   TI
   LI
   LO
   TS
CL000641 PLC/PRF/5 Homo sapiens (Human)  1
1
IC50 = 54700 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 800 nM
2 IC50 = 2400 nM
3 IC50 = 2500 nM
4 IC50 = 2626.629483 nM
5 IC50 = 2700 nM
6 IC50 = 3500 nM
7 IC50 = 3900 nM
8 IC50 = 16000 nM
9 IC50 = 19400 nM
10 IC50 = 35500 nM
11 IC50 = 40000 nM
12 IC50 = 54700 nM
Protein ID: PT04212, Endoplasmic reticulum aminopeptidase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000023 BTI-Tn-5B1-4 Trichoplusia ni (Cabbage looper)  1
1
IC50 = 45000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01964, Endoplasmic reticulum aminopeptidase 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000023 BTI-Tn-5B1-4 Trichoplusia ni (Cabbage looper)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Protein ID: PT05005, Interleukin-1 receptor antagonist protein
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000107 HEK293S Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Protein ID: PT06345, Solute carrier family 15 member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000009 LLC-PK1 Sus scrofa (Pig)  1
1
Ki = 18000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000002 K-562 Homo sapiens (Human)  1
1
IC50 > 500000 nM
   TI
   LI
   LO
   TS
CL000018 HL-60 Homo sapiens (Human)  1
1
IC50 = 1340000 nM
   TI
   LI
   LO
   TS
CL000067 HCT 116 Homo sapiens (Human)  1
1
IC50 > 500000 nM
   TI
   LI
   LO
   TS
CL000068 A-549 Homo sapiens (Human)  1
1
IC50 > 500000 nM
   TI
   LI
   LO
   TS
CL000100 U-937 Homo sapiens (Human)  1
1
IC50 > 500000 nM
   TI
   LI
   LO
   TS
CL000111 MDA-MB-231 Homo sapiens (Human)  2
1
IC50 = 753180 nM
   TI
   LI
   LO
   TS
2
IC50 = 5080000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Bestatin )
Drug Name Bestatin
Indication
Acute myeloid leukaemia
Approved
Target(s)
Leukotriene A-4 hydrolase (LTA4H)
Inhibitor